Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats
Hai‐Ying Zhang, Ming Gao, Hui Shen, et al.
Addiction Biology (2016) Vol. 22, Iss. 3, pp. 752-765
Open Access | Times Cited: 135

Showing 1-25 of 135 citing articles:

Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Debra A. Kendall, Guillermo A. Yudowski
Frontiers in Cellular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 304
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Eric P. Baron
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. 7, pp. 1139-1186
Closed Access | Times Cited: 212
Progress in brain cannabinoid CB2 receptor research: From genes to behavior
Chloe J. Jordan, Zheng‐Xiong Xi
Neuroscience & Biobehavioral Reviews (2019) Vol. 98, pp. 208-220
Open Access | Times Cited: 165
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
Eric P. Baron, Philippe Lucas, Joshua Eades, et al.
The Journal of Headache and Pain (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 159
Endocannabinoid modulation of dopamine neurotransmission
Dan P. Covey, Yolanda Mateo, David Sulzer, et al.
Neuropharmacology (2017) Vol. 124, pp. 52-61
Open Access | Times Cited: 153
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference
Qing‐Rong Liu, Ana Canseco-Alba, Hai‐Ying Zhang, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 134
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts
Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 1, pp. 88-127
Open Access | Times Cited: 132
CB2 Receptor in Microglia: The Guardian of Self-Control
Joanna Agnieszka Komorowska‐Müller, Anne‐Caroline Schmöle
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 19-19
Open Access | Times Cited: 122
Current evidence of cannabinoid‐based analgesia obtained in preclinical and human experimental settings
Jörn Lötsch, Iris Weyer-Menkhoff, Irmgard Tegeder
European Journal of Pain (2017) Vol. 22, Iss. 3, pp. 471-484
Open Access | Times Cited: 114
Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms
Ewa Galaj, Guo‐Hua Bi, Hongju Yang, et al.
Neuropharmacology (2019) Vol. 167, pp. 107740-107740
Open Access | Times Cited: 106
Role of the endocannabinoid system in drug addiction
Jorge Manzanares, David Cabañero, Nagore Puente, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 108-121
Open Access | Times Cited: 103
Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain
Jennifer M. Wenzel, Erik B. Oleson, Willard N. Gove, et al.
Current Biology (2018) Vol. 28, Iss. 9, pp. 1392-1404.e5
Open Access | Times Cited: 90
Brain activity of anandamide: a rewarding bliss?
María Scherma, Paolo Masia, Valentina Satta, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 3, pp. 309-323
Open Access | Times Cited: 86
Neurobiology of cannabinoid receptor signaling
Beat Lutz
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 207-222
Open Access | Times Cited: 79
Endocannabinoids, cannabinoids and the regulation of anxiety
Gavin N. Petrie, Andrei S. Nastase, Robert J. Aukema, et al.
Neuropharmacology (2021) Vol. 195, pp. 108626-108626
Closed Access | Times Cited: 59
CB2 receptor in the CNS: From immune and neuronal modulation to behavior
Wanda Grabon, Sylvain Rheims, Jonathon Smith, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 150, pp. 105226-105226
Open Access | Times Cited: 27
A review of the effects of different types of social behaviors on the recruitment of neuropeptides and neurotransmitters in the nucleus accumbens
Johnathan M. Borland
Frontiers in Neuroendocrinology (2025), pp. 101175-101175
Closed Access | Times Cited: 1
Cannabinoid receptor type-1: breaking the dogmas
Arnau Busquets‐Garcia, Edgar Soria‐Gómez, Luigi Bellocchio, et al.
F1000Research (2016) Vol. 5, pp. 990-990
Open Access | Times Cited: 63
CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice
Xiao Han, Yi He, Guo-Hua Bi, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 62
Zebrafish models relevant to studying central opioid and endocannabinoid systems
Konstantin A. Demin, Darya A. Meshalkina, Elana V. Kysil, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 86, pp. 301-312
Closed Access | Times Cited: 60
Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats
Krista J. Spiller, Guo‐Hua Bi, Yi He, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 9, pp. 1268-1281
Open Access | Times Cited: 60
Mechanisms of cannabinoid CB2 receptor-mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area
Zegang Ma, Fenfei Gao, Brett Larsen, et al.
EBioMedicine (2019) Vol. 42, pp. 225-237
Open Access | Times Cited: 59
Advancing the science on cannabis concentrates and behavioural health
L. Cinnamon Bidwell, Renée Martin‐Willett, Hollis C. Karoly
Drug and Alcohol Review (2021) Vol. 40, Iss. 6, pp. 900-913
Open Access | Times Cited: 43
CB2R Activation Regulates TFEB-Mediated Autophagy and Affects Lipid Metabolism and Inflammation of Astrocytes in POCD
Lieliang Zhang, Xifeng Wang, Wen Yu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions
Natalie E. Zlebnik, Joseph F. Cheer
Journal of Neuroscience (2016) Vol. 36, Iss. 40, pp. 10230-10238
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top